Clopitab Tablet 15

Here are the categorised explanations of drug interactions with specific drugs:

• Warfarin: When taken with warfarin, an anticoagulant medication, Clopidogrel may raise the risk of bleeding.
• Aspirin: Combining Clopitab 75mg tablet with aspirin may increase the risk of bleeding.
• Rivaroxaban and Apixaban: Concurrent use of Clopitab 75mg tablet with rivaroxaban or apixaban, other antiplatelet or anticoagulant medications, may increase the risk of bleeding.
• Ibuprofen: Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), may raise the likelihood of bleeding when used with Clopitab 75mg tablet.
• Citalopram: Citalopram, an antidepressant, may increase the risk of bleeding when used with Clopitab 75mg tablet.
• Omeprazole: Omeprazole, a proton pump inhibitor, may reduce the effectiveness of Clopitab 75mg tablet by inhibiting its activation.

Here are the categorised explanations of drug-food interactions:

Grapefruit and Grapefruit Juice:

Grapefruit and grapefruit juice can interfere with the breakdown of Clopitab 75mg tablet in the body, leading to increased drug levels and a potentially higher likelihood of adverse effects.

When taking a 75mg Clopitab tablet, avoiding consuming grapefruit or grapefruit juice is advised. Consult your doctor if you have any worries or inquiries.

Alcohol:

Alcohol can increase the risk of gastrointestinal bleeding when used with Clopitab 75mg tablet. It is advisable to reduce or avoid alcohol consumption while taking Clopitab 75mg tablet to reduce the risk of bleeding complications.

Some significant drug-disease interactions associated with Clopitab 75mg tablet:

Bleeding Disorders:

Clopitab 75mg tablet can increase the risk of bleeding. Individuals with bleeding disorders, such as haemophilia, a history of stroke or von Willebrand disease, may be at a higher risk of bleeding complications. 

Clopitab 75mg tablet should be used cautiously in individuals with bleeding disorders. Close monitoring by a healthcare provider is vital to assess the benefits and risks of treatment.

Liver Disease:

Clopitab 75mg tablet is metabolised in the liver. Severe liver disease can affect the breakdown and clearance of the medication.

Clopitab 75mg tablet should be used carefully in individuals with severe liver disease. Regular monitoring by a healthcare professional is essential, and dosage modifications may be required.

Kidney Disease:

Clopitab 75mg tablet is primarily excreted through the kidneys. Kidney disease can affect the elimination of the medication from the body.

Clopitab 75mg tablet should be used cautiously in individuals with kidney disease. It's crucial to have a healthcare professional closely watch you; dose modifications would be necessary.

The recommended dose of Clopitab is 75 mg tablet once daily, with food, as directed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is essential to follow the suggested dosage and not exceed it without consulting your doctor. 

If you or someone else takes excessive Clopitab 75 mg tablet by accident, it is essential to take immediate medical attention from your doctor or nearby hospital. An overdose's symptoms include nausea and vomiting, stomach upset and gastric pain, drowsiness and bleeding.

If you forgot to take Clopitab 75 mg tablet, take it as soon as you recall or as your health care provider instructed. If the time for the next dosage is close, skipping the missed one is recommended and resume your regular dosage pattern. Never increase your dosage without consulting your doctor.